Overview

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Oral Single Dose of TAK-418 in Healthy Participants

Status:
Completed

Trial end date:
2018-05-12

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and tolerability of TAK-418 following single oral doses in healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Takeda